About us
More
09.04.2019
Alibion kicks off pre-clinical studies to address Rheumatoid arthritis
26.07.2019
Alibion received 10,000 CHF grant from VentureKick jury after pitching our business plan!
15.10.2019
Alibion selected as 1 of 15 companies chosen for Phase 1 of BaseLaunch
